DoD Melanoma, Melanoma Academy Leadership Award
ID: 358953Type: Posted
Overview

Buyer

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the Melanoma Academy Leadership Award, a federal grant aimed at establishing a Director and Deputy Director for the Melanoma Research Program's virtual academy. This initiative seeks to cultivate high-performing melanoma researchers by fostering mentorship and collaboration between established and early-career investigators, with a focus on enhancing patient outcomes and reducing the burden of melanoma. The total estimated funding for this opportunity is approximately $2.1 million, supporting one application with a direct cost cap of $1.3 million over a maximum performance period of four years. Interested applicants must submit a pre-application by October 1, 2025, and can reach out to the CDMRP Help Desk at help@eBRAP.org for further inquiries.

    Point(s) of Contact
    Files
    Title
    Posted
    The Department of Defense's FY25 Melanoma Academy Leadership Award funding opportunity aims to secure a Director and Deputy Director for the Melanoma Research Program’s virtual academy. This initiative seeks to cultivate high-performing melanoma researchers through mentorship and collaboration. The award, with an estimated budget of $2.1 million, will support one application with a combined direct cost cap of $1.3 million over a maximum of four years. Eligible applicants include established melanoma researchers from various organizations, including domestic and foreign entities. This document outlines the funding mechanism, application process, eligibility criteria, evaluation plans, and submission details designed for a two-step application process—starting with a pre-application and followed by a full application submission. Key focus areas include melanoma prevention, research on rare melanomas, and survivorship, emphasizing studies that aim to enhance patient outcomes and reduce melanoma burdens. The Melanoma Academy aims to foster collaboration among early-career investigators and experienced mentors, contributing to advances in melanoma research relevant to military health. Successful applicants are expected to engage actively in developing the academy's vision and managing its activities, with oversight from the Consumer Consultant Panel and an Advisory Board.
    Similar Opportunities
    DoD Melanoma, Melanoma Academy Scholar Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the Congressionally Directed Medical Research Programs (CDMRP), is offering the FY25 Melanoma Academy Scholar Award to support early-career melanoma researchers. This grant aims to foster independent scientists who are within seven years of their initial faculty appointment by integrating them into a virtual collaborative academy that emphasizes mentorship and research development in melanoma. The program is particularly focused on three strategic research priorities: prevention and interception, studies on rare melanoma subtypes, and survivorship research, with a total funding allocation of approximately $1.76 million for two awards, each capped at $550,000 over a maximum period of three years. Interested applicants must submit a pre-application by September 10, 2025, followed by a full application due on October 1, 2025, and can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DoD Melanoma, Team Science Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), has announced the DoD Melanoma Team Science Award, a federal grant opportunity aimed at advancing melanoma research and patient care through multidisciplinary studies. This program requires collaboration among at least two to three Principal Investigators (PIs) from various institutions to address complex issues impacting patient outcomes, with a focus on innovative research areas such as prevention, interception, and survivorship related to melanoma. Approximately $16.8 million is available to fund around seven applications, with a direct cost cap of $1.5 million and a maximum project duration of three years. Interested applicants must submit a pre-application by June 30, 2025, followed by invited full applications due by October 1, 2025. For further inquiries, contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Melanoma, Idea Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY25 Melanoma Research Program Idea Award to support innovative and exploratory research related to melanoma. This grant aims to fund high-risk, potentially high-reward projects that focus on areas such as melanoma prevention, rare melanoma research, or survivorship impacts, with a maximum direct cost of $400,000 available for each project over a two-year period. The program is particularly significant for advancing melanoma detection, treatment, and survivorship, especially in the context of military health concerns. Interested applicants must submit a pre-application by June 30, 2025, followed by a full application due by October 1, 2025, with a total funding pool of approximately $5.76 million available for about nine awards. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Melanoma, Survivorship Research Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY25 Melanoma Survivorship Research Award to support innovative research aimed at enhancing the health and well-being of melanoma survivors and their caregivers. This grant encourages collaborative research that integrates insights from melanoma consumers, with a focus on various aspects of survivorship, including psychological impacts, symptom management, and healthcare delivery challenges, while explicitly excluding studies limited to animal models or survival rates without quality of life considerations. The total estimated program funding is $2,320,000, with a maximum award amount of $725,000 per project over a three-year performance period. Interested applicants must submit a pre-application by September 10, 2025, followed by a full application due by October 1, 2025, and can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DoD Melanoma, Focused Program Award – Rare Melanomas
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering a funding opportunity for the DoD Melanoma, Focused Program Award aimed at advancing research on rare melanomas. This grant supports multidisciplinary teams to propose two to three complementary research projects centered around a common overarching question related to rare melanomas, with an emphasis on collaboration among Principal Investigators (PIs) from various institutions. The total funding available is $6.4 million, with approximately two awards expected, each providing up to $2 million over a maximum four-year period. Interested applicants must submit a pre-application by June 30, 2025, and, if invited, a full application by October 1, 2025. For further inquiries, contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DOD Ovarian Cancer, Clinical Trial Academy – Early-Career Investigator Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the Ovarian Cancer Clinical Trial Academy – Early-Career Investigator Award for Fiscal Year 2025. This grant aims to support early-career investigators in conducting clinical trials focused on ovarian cancer, emphasizing professional development, intensive mentoring, and networking opportunities. The program is critical for enhancing the research landscape in ovarian cancer, with an estimated total funding of approximately $1.4 million available for a maximum of four years. Interested applicants must submit a pre-application by June 12, 2025, followed by a full application due on September 11, 2025, and can reach out to the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507 for further information.
    DOD Peer Reviewed Cancer, Career Development Award – Scholar Option
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the Peer Reviewed Cancer Research Program (PRCRP) Career Development Award – Scholar Option (CDA-SO) for fiscal year 2025. This grant aims to support independent early-career investigators, referred to as Scholars, in conducting impactful cancer research under the mentorship of an experienced Career Guide, with a focus on military health-related cancer issues. The program has an estimated total funding of approximately $9.9 million, with about nine awards anticipated, each capped at $1.1 million. Interested applicants must submit a pre-application by June 19, 2025, followed by a full application due by July 3, 2025. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    Alzheimer’s Research Program Transforming Research Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the Alzheimer's Research Program Transforming Research Award to support innovative research aimed at reducing the risk of Alzheimer's disease and related dementias (AD/ADRD). This grant opportunity encourages diverse applicants, including for-profit, non-profit, and academic institutions, and emphasizes the necessity of community collaboration, particularly for clinical research projects. With an estimated total program funding of $4 million, the program anticipates awarding approximately four grants, each providing up to $1 million over a maximum of three years. Interested applicants must submit a pre-application by June 12, 2025, followed by a full application due by August 29, 2025. For further inquiries, contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DOD Peer Reviewed Cancer, Idea Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the fiscal year 2025 Peer Reviewed Cancer Research Program (PRCRP) Idea Award to support innovative cancer research that prioritizes military health. This grant aims to fund high-risk, high-reward proposals that focus on specific cancer types relevant to Service Members, Veterans, and their families, with an emphasis on introducing new paradigms in cancer care and addressing environmental exposure risks. With an estimated total program funding of approximately $14 million, the program anticipates awarding around 25 projects, each with a maximum funding limit of $560,000 for a duration of up to two years. Interested applicants must submit a pre-application by June 20, 2025, followed by a full application due by September 25, 2025; for further inquiries, contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DOD Peer Reviewed Cancer, Impact Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY25 Peer Reviewed Cancer Research Program (PRCRP) Impact Award to support high-impact research aimed at improving clinical cancer care relevant to military health. This grant seeks mature research projects that demonstrate potential for near-term benefits in cancer treatment and patient outcomes, particularly focusing on specific cancer types such as bladder, blood, and brain cancers, while excluding melanoma and breast cancers. The program emphasizes the importance of preliminary data, collaboration with Department of Defense (DOD) and Veterans Affairs (VA) entities, and rigorous study designs to advance cancer detection and treatment for service members and their families. The estimated total program funding is $45.5 million, with individual awards capped at $1.4 million for single Principal Investigator applications and $1.75 million for partnering applications, over a maximum period of three years. Interested applicants must submit a pre-application by September 25, 2025, and can contact the CDMRP Help Desk at help@eBRAP.org for further assistance.